Concord Biotech Ltd. Financial Overview
Concord Biotech Ltd.'s market cap is currently ₹144.28B. The company's EPS TTM is ₹6; its P/E ratio is 44.54; and it has a dividend yield of 0.77%. Concord Biotech Ltd. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
